GLP-1 Compounding: Court Backs US FDA Approach To Managing Drug Shortage List

 
• By Sue Sutter
  
MIsaligned pencils
A court said the notice-and-comment rulemaking process is not aligned with Congress' mandate that the FDA keep an up-to-date list of drugs in shortage. (Shutterstock)

More from Litigation

More from Legal & IP